drugset / Trial / NCT00645268

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

NCT00645268

Phase 4 Completed 300 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To determine the effect on erectile function in a population of type 2 diabetic men with erectile dysfunction who have undergone the following treatment regimen: pre-treatment with a daily dose of double-blind sildenafil versus placebo for 4 weeks (Phase I) followed by an as-needed, flexible-dose, open-label treatment phase with sildenafil for 12 weeks (Phase II). To assess safety and tolerability of this dosing regimen and to investigate its effects on endothelial function and subject's responses to the Self-Esteem And Relationship (SEAR) questionnaire.

Timeline

Start
2002-12
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 25 mg
Subject Sildenafil Unknown 100 mg